Egalet is a commercial-stage company focused on bringing pain products to the patients and physicians who treat them. Given the need for acute and chronic pain products and the issue of prescription opioid abuse, Egalet is primarily focused on commercializing non-narcotic and abuse-discouraging products. The Company plans to continue to grow revenue of its seven commercial products and explore business development opportunities. Egalet has a pipeline of development-stage products and platform technology which it may look to partner or develop in the future.
For more information about our products, including boxed warnings, please visit www.egalet.com/our-products/.